Compare EMBC & LZM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EMBC | LZM |
|---|---|---|
| Founded | 1924 | 2021 |
| Country | United States | Isle of Man |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Metal Mining |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 328.1M | 336.3M |
| IPO Year | 2021 | 2023 |
| Metric | EMBC | LZM |
|---|---|---|
| Price | $6.32 | $3.11 |
| Analyst Decision | Hold | |
| Analyst Count | 4 | 0 |
| Target Price | $4.00 | ★ $9.44 |
| AVG Volume (30 Days) | ★ 941.5K | 451.0K |
| Earning Date | 11-24-2026 | 07-29-2026 |
| Dividend Yield | ★ 0.62% | N/A |
| EPS Growth | ★ 20.90 | N/A |
| EPS | ★ 1.03 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $41.91 |
| Revenue Next Year | $5.59 | N/A |
| P/E Ratio | $6.26 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.77 | $3.00 |
| 52 Week High | $14.91 | $6.40 |
| Indicator | EMBC | LZM |
|---|---|---|
| Relative Strength Index (RSI) | 66.56 | 33.13 |
| Support Level | $3.01 | $3.03 |
| Resistance Level | $9.38 | $4.17 |
| Average True Range (ATR) | 0.28 | 0.19 |
| MACD | 0.03 | -0.05 |
| Stochastic Oscillator | 77.52 | 1.18 |
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.
Lifezone Metals Ltd seeks to support the clean energy transition through the licensing of Hydromet Technology as an alternative to smelting and metals refining. Its business comprises three segments: Metals extraction and refining for developing and operating a vertically integrated base metal operation in the northwest region of Tanzania, and Intellectual property licensing comprises patents residing with and managed by the subsidiary and corporate. Geographically, the company operates in South Africa, Australia, and the rest of the world. The majority of its revenue is generated from Australia.